Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Neurol Sci ; 24(3): 225-6, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14600828

RESUMEN

Fatigue is a recognized problem in Parkinson's disease and other clinical conditions. We characterized this symptom in 19 patients and 19 age- and sex-matched controls, using the Multidimensional Fatigue Inventory (MFI) and the Geriatric Depression Scale. Fatigue may be an independent symptom in Parkinson's disease, frequently associated with depression. Our analysis showed the usefulness of the MFI in discriminating between different dimensions of fatigue for a better therapeutic approach.


Asunto(s)
Fatiga/etiología , Enfermedad de Parkinson/complicaciones , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Motivación , Análisis Multivariante , Escalas de Valoración Psiquiátrica , Psicometría , Calidad de Vida , Reproducibilidad de los Resultados , Índice de Severidad de la Enfermedad , Perfil de Impacto de Enfermedad , Encuestas y Cuestionarios
2.
Neurol Sci ; 23 Suppl 2: S81-2, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12548354

RESUMEN

We ascertained the prevalence of apraxia of eyelid opening (AEO) in a community located in Puglia, a region of southern Italy. The crude prevalence rate was 59 per million (95% confidence interval, 24-173). AEO coexisted with adult onset blepharospasm in 75% of cases, with atypical parkinsonism in 25% of cases. Among the overall patient population seen at our movement disorders clinic from 1987 to 1997, AEO was isolated in 10 otherwise healthy individuals, associated with adult-onset dystonia in 13 cases, and associated with a parkinsonian syndrome in 9 cases. The frequency of AEO was 10.8% in the dystonia group, and 2.1% in the overall parkinsonian group (Parkinson's disease, 0.7%; progressive supranuclear palsy, 33.3%). In two patients with possible progressive supranuclear palsy, AEO worsened after increasing levodopa dosage or acute apomorphine challenge and disappeared following levodopa discontinuation. AEO developing in the setting of a parkinsonian syndrome may be either disease- or drug-related.


Asunto(s)
Antiparkinsonianos/efectos adversos , Apraxias/epidemiología , Apraxias/etiología , Blefaroespasmo/complicaciones , Párpados , Parálisis Supranuclear Progresiva/complicaciones , Adulto , Edad de Inicio , Anciano , Apomorfina/efectos adversos , Distonía/complicaciones , Párpados/fisiopatología , Femenino , Humanos , Italia/epidemiología , Levodopa/efectos adversos , Masculino , Persona de Mediana Edad , Trastornos Parkinsonianos/complicaciones
3.
Neurol Sci ; 22(1): 109-10, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11487183

RESUMEN

A clinical retrospective study was carried out in a population of 366 Parkinson's disease (PD) outpatients, to analyse the efficacy and tolerability of nonergoline and ergoline dopamine agonist (DA), in monotherapy or in combination with L-dopa. Safety was comparable in both groups except for higher occurrence of gastrointestinal symptoms in ergoline group and somnolence in nonergoline group. No significant difference concerning efficacy and tolerability was found during DA monotherapy. Mean age at PD onset was slightly higher in patients withdrawing DA monotherapy for adverse events comparing to patients who needed the addition of L-dopa (60.36 +/- 7.53 versus 54.88 +/- 10.75; p<0.05), suggesting that older age at the onset of the disease increases the risk for adverse events during DA monotherapy. The follow-up of the remaining patients still in monotherapy with DA will allow a better evaluation of these aspects.


Asunto(s)
Envejecimiento/efectos de los fármacos , Agonistas de Dopamina/efectos adversos , Tolerancia a Medicamentos/fisiología , Enfermedad de Parkinson/tratamiento farmacológico , Edad de Inicio , Anciano , Envejecimiento/fisiología , Benzotiazoles , Bromocriptina/administración & dosificación , Bromocriptina/efectos adversos , Agonistas de Dopamina/administración & dosificación , Esquema de Medicación , Interacciones Farmacológicas/fisiología , Quimioterapia Combinada , Ergolinas/administración & dosificación , Ergolinas/efectos adversos , Ergolinas/agonistas , Femenino , Estudios de Seguimiento , Humanos , Indoles/administración & dosificación , Indoles/efectos adversos , Levodopa/administración & dosificación , Levodopa/efectos adversos , Lisurida/administración & dosificación , Lisurida/efectos adversos , Masculino , Persona de Mediana Edad , Pergolida/administración & dosificación , Pergolida/efectos adversos , Pramipexol , Estudios Retrospectivos , Tiazoles/administración & dosificación , Tiazoles/efectos adversos , Resultado del Tratamiento
4.
Neurol Sci ; 22(5): 391-4, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11917977

RESUMEN

Paroxysmal dystonia (PD) is a usually painful, unilateral dystonic posture, precipitated by voluntary movement, tactile stimulation, startling noise or hyperventilation. We describe two cases of paroxysmal dystonia in multiple sclerosis, both with a critically localized lesion in the thalamus, contralateral to the paroxysmal symptoms. Only one other case of paroxysmal dystonia with a demyelinated lesion of the thalamus has been reported previously.


Asunto(s)
Distonía/etiología , Esclerosis Múltiple/complicaciones , Enfermedades Talámicas/etiología , Tálamo/fisiopatología , Adolescente , Distonía/patología , Distonía/fisiopatología , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/patología , Esclerosis Múltiple/fisiopatología , Enfermedades Talámicas/patología , Enfermedades Talámicas/fisiopatología , Tálamo/patología , Resultado del Tratamiento
5.
Neuroradiology ; 42(12): 930-2, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11198216

RESUMEN

The Klippel-Trenaunay syndrome (KTS) is a congenital disorder resulting from a mesodermal abnormality, characterised by cutaneous capillary haemangiomas, hypertrophy of bone and soft tissues and varicose veins. The presence of intracranial aneurysms has rarely been described, while oesophageal duplication has not been reported previously. We describe a patient with the KTS with both there additional abnormalities, which could be explained by a postulated mosaic gene abnormality.


Asunto(s)
Anomalías Múltiples , Esófago/anomalías , Aneurisma Intracraneal/patología , Síndrome de Klippel-Trenaunay-Weber/complicaciones , Adulto , Humanos , Aneurisma Intracraneal/genética , Síndrome de Klippel-Trenaunay-Weber/genética , Síndrome de Klippel-Trenaunay-Weber/patología , Imagen por Resonancia Magnética , Masculino
6.
Artículo en Inglés | MEDLINE | ID: mdl-11969861

RESUMEN

We describe the multiresolution wavelet analysis of blood pressure waves in vasovagal syncope-affected patients compared with those in healthy people, using Haar and Gaussian bases. A comparison between scale-dependent and scale-independent measures discriminating the two classes of subjects is made. What emerges is a sort of equivalence between these two methodological approaches, that is, both methods reach the same statistical significance of separation between the two classes.


Asunto(s)
Biofisica , Presión Sanguínea , Estadística como Asunto , Fenómenos Biofísicos , Humanos , Distribución Normal , Síncope Vasovagal/diagnóstico , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...